NDA: 353
UPA: 92
(180 seats to win)OTH: 97
(175 seats to win)Lok Sabha 2019 Election Results LiveClick Here »
Co-Partners
Associate Partners
| 5-Day | 24,034 |
| 10-Day | 26,597 |
| 30-Day | 18,090 |
| 5-Day | 24,034 |
| 10-Day | 26,597 |
| 30-Day | 18,090 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 100 | 1765.15 | 1768.80 | 1 |
| 10 | 1762.00 | 1769.80 | 60 |
| 1 | 1750.00 | 1769.90 | 400 |
| 15 | 1748.50 | 1770.00 | 43 |
| 1 | 1742.00 | 1772.00 | 11 |
| 1588 | Total | 1065 | Total |
Buy Qty
1588
Sell QTY
1065
| 5-Day | 444,943 |
| 10-Day | 467,440 |
| 30-Day | 444,238 |
| 5-Day | 444,943 |
| 10-Day | 467,440 |
| 30-Day | 444,238 |
Divis Labs
Sentimeter
100% of moneycontrol users recommend buying Divis Labs.
What's your call on Divis Labs today?
Read 1 investor views
| Days | BSE | NSE |
| 30 | 1692.69 | 1693.09 |
| 50 | 1692.14 | 1692.34 |
| 150 | 1568.81 | 1569.15 |
| 200 | 1492.64 | 1493.07 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Divis Labs
| Standalone | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
| Net Sales | 1,342.92 | 1,285.00 | 995.31 | 1,087.95 |
| Other Income | 34.56 | 80.05 | 48.79 | 48.17 |
| PBDIT | 523.33 | 514.13 | 351.86 | 386.50 |
| Net Profit | 379.49 | 397.65 | 266.16 | 261.60 |
| Total Share Capital | 53.09 |
| Net Worth | 5,959.65 |
| Total Debt | 63.11 |
| Net Block | 1,995.88 |
| Investments | 1,896.66 |
| Total Assets | 6,022.76 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 415.55 | 0.56 | 678.80 | 350.40 | 99,704.36 |
| Divis Labs | 1762.40 | 1.77 | 1768.80 | 994.95 | 46,786.18 |
| Cipla | 570.35 | 1.22 | 678.00 | 483.75 | 45,955.50 |
| Dr Reddys Labs | 2664.20 | 1.02 | 2965.20 | 1934.35 | 44,243.29 |
| Piramal Enter | 2198.70 | 1.44 | 3302.55 | 1796.75 | 43,677.34 |
| More » | |||||
| Mar' 19 | Dec' 18 | Dec' 18 | Sep' 18 | |
| Promoter | 52.01 | 52.01 | 52.01 | 52.02 |
| Public (FII + DII) | 47.99 | 47.99 | 47.99 | 47.98 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| SBI Equity Hybrid Fund (G) | 4,308,882 |
| SBI Blue Chip Fund (G) | 2,023,533 |
| Reliance Multi Cap Fund - Retail Plan (G) | 1,894,396 |
| HDFC Mid-Cap Opportunities Fund (G) | 1,690,748 |
HDFC Bank Recommended on Jun 5th 2017
Recommended price 1,636.00 | Peak from reco 2449.00 49.71%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Divis Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 46,786.18 crore.
The company management includes Murali K Divi - Chairman & Managing Director, Madhusudana Rao Divi - Whole Time Director, Kiran S Divi - Whole Time Director, Nilima Motaparti - Whole Time Director, N V Ramana - Executive Director, K V K Seshavataram - Independent Director, G Suresh Kumar - Independent Director, R Ranga Rao - Independent Director, Ramesh B V Nimmagadda - Independent Director, S Ganapaty - Independent Director, Sunaina Singh - Independent Director.
It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB.
Its Registered office is at Divi Towers, 1-72/23(P)/DIVIS/303,,Cyber Hills, Gachibowli, Hyderabad,Telangana - 500032.
Their Registrars are Karvy Computershare Private Ltd.
SET SMS ALERT
